These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3073659)

  • 41. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
    Klaassen U; Harstrick A; Wilke H; Seeber S
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
    Jones SE; Mennel RG; Brooks B; Westrick MA; Allison MA; Paulson RS; Tilmann K; Rea B
    J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
    Stöger H; Schmid M; Bauernhofer T; Moser R; Ploner F; Derstvenscheg E; Kasparek AK; Kuss I; Wilders-Truschnig M; Lackner C
    Oncology; 1994; 51(6):518-22. PubMed ID: 7970497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A northern California Oncology Group randomized trial of single agent 5-FU vs. high-dose folinic acid + 5-FU vs. methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer.
    Valone FH; Wittlinger PS; Flam MS; Drakes T; Eisenberg PD; Hannigan J
    Adv Exp Med Biol; 1988; 244():193-9. PubMed ID: 3073654
    [No Abstract]   [Full Text] [Related]  

  • 45. Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer.
    Kuehr T; Ruff P; Rapoport BL; Falk S; Daniel F; Jacobs C; Davidson N; Thaler J; Boussard B; Carmichael J
    BMC Cancer; 2004 Jul; 4():36. PubMed ID: 15257756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
    Lichinitser MR; Vyshinskaia GV; Gritsaĭ AA; Kondrat'eva AP; Luk'ianchenko AB
    Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer previously treated with a fluoropyrimidine-based regimen.
    Kim SH; Lee GW; Go SI; Cho SH; Kim HJ; Kim HG; Kang JH
    Am J Clin Oncol; 2010 Dec; 33(6):572-6. PubMed ID: 20042971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patients.
    Mammoliti S; Merlini L; Caroti C; Gallo L
    Eur J Cancer; 1994; 30A(2):248-9. PubMed ID: 8155400
    [No Abstract]   [Full Text] [Related]  

  • 49. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
    Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
    Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of bone metastasis from gastric carcinoma after a nine-year disease-free interval.
    Kammori M; Seto Y; Haniuda N; Kawahara M; Takubo K; Endo H; Kaminishi M
    Jpn J Clin Oncol; 2001 Aug; 31(8):407-9. PubMed ID: 11574636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y; Une Y; Fujisawa J; Uchino J
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
    Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
    Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
    Hartmann JT; Pintoffl JP; Al-Batran SE; Quietzsch D; Meisinger I; Horger M; Nehls O; Bokemeyer C; Königsrainer A; Jäger E; Kanz L
    Onkologie; 2007 May; 30(5):235-40. PubMed ID: 17460417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C; Fine S; Wong A; Elhakim T
    J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
    Wein A; Riedel C; Brückl W; Kastl S; Reingruber B; Hohenberger W; Hahn EG
    Z Gastroenterol; 2001 Feb; 39(2):153-6. PubMed ID: 11253506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.
    Deprés-Brummer P; Berthault-Cvitkovic F; Lĕvi F; Brienza S; Vannetzel JM; Jasmin C; Misset JL
    J Infus Chemother; 1995; 5(3 Suppl 1):144-7. PubMed ID: 8528975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer.
    Lemmens J; Berteloot P; Thomas J; Wildiers J; Paridaens R
    Eur J Cancer; 1995 Nov; 31A(12):2114-5. PubMed ID: 8562176
    [No Abstract]   [Full Text] [Related]  

  • 59. A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
    Lin CC; Cheng AL; Hsu CH; Lu YS; Hsu C; Yeh KH; Wu CY; Huang CS; Yang CH
    Anticancer Res; 2007; 27(1B):641-5. PubMed ID: 17348454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.
    Kondoh C; Kadowaki S; Komori A; Narita Y; Taniguchi H; Ura T; Ando M; Muro K
    Gastric Cancer; 2018 Nov; 21(6):1050-1057. PubMed ID: 29658055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.